Open Access. Powered by Scholars. Published by Universities.®
Immunoprophylaxis and Therapy Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medicine and Health Sciences (30)
- Immunity (26)
- Diseases (18)
- Immunology of Infectious Disease (18)
- Microbiology (14)
-
- Genetics and Genomics (12)
- Medical Specialties (11)
- Biochemistry, Biophysics, and Structural Biology (9)
- Cell and Developmental Biology (8)
- Virology (8)
- Animal Sciences (7)
- Genetics (7)
- Immunopathology (7)
- Medical Sciences (7)
- Biochemistry (6)
- Biology (6)
- Medical Immunology (6)
- Physical Sciences and Mathematics (6)
- Molecular Biology (5)
- Molecular Genetics (5)
- Neoplasms (5)
- Pathogenic Microbiology (5)
- Pharmacology, Toxicology and Environmental Health (5)
- Virus Diseases (5)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (4)
- Bacterial Infections and Mycoses (4)
- Biomedical Engineering and Bioengineering (4)
- Institution
-
- Selected Works (11)
- The Texas Medical Center Library (6)
- The University of Maine (5)
- Touro College and University System (4)
- Rowan University (3)
-
- University of Central Florida (3)
- Claremont Colleges (2)
- Himmelfarb Health Sciences Library, The George Washington University (2)
- Seton Hall University (2)
- University of Connecticut (2)
- University of Massachusetts Amherst (2)
- University of Nebraska - Lincoln (2)
- Augustana College (1)
- Cedarville University (1)
- Duke Law (1)
- Georgia State University (1)
- Missouri State University (1)
- SIT Graduate Institute/SIT Study Abroad (1)
- Saint Louis University School of Law (1)
- Southeastern University (1)
- The University of Southern Mississippi (1)
- University of Arkansas, Fayetteville (1)
- University of Kentucky (1)
- University of Missouri, St. Louis (1)
- University of Montana (1)
- University of Nebraska Medical Center (1)
- University of Northern Colorado (1)
- University of Tennessee, Knoxville (1)
- Virginia Commonwealth University (1)
- West Virginia University (1)
- Keyword
-
- Vaccine (5)
- Humans (4)
- Immunotherapy (4)
- Adjuvant (3)
- Antigen (3)
-
- Cancer (3)
- HIV-1 (3)
- Immune response (3)
- PD-1 (3)
- Vaccinations (3)
- Vaccines (3)
- Aging (2)
- Anthrax (2)
- CTB (2)
- Cytokines (2)
- Epitope (2)
- Gene therapy (2)
- HIV (2)
- Immunoediting (2)
- Immunology (2)
- Immunometabolism (2)
- Immunosurveillance (2)
- Inflammation (2)
- Mutation (2)
- PD-L1 (2)
- TLR4 (2)
- Tobacco Mosaic Virus (2)
- Transgenic mouse model of cancer (2)
- UMCCTS funding (2)
- *HIV Long Terminal Repeat (1)
- Publication Year
- Publication
-
- Dissertations & Theses (Open Access) (6)
- 2nd International Conference of Fish & Shellfish Immunology (5)
- The Science Journal of the Lander College of Arts and Sciences (4)
- Celia A. Schiffer (3)
- Doctoral Dissertations (3)
-
- Christian Mueller (2)
- Gyongyi Szabo (2)
- Honors Undergraduate Theses (2)
- KGI Theses and Dissertations (2)
- Qingsheng Li Publications (2)
- Seton Hall University Dissertations and Theses (ETDs) (2)
- All Faculty Scholarship (1)
- Associate Professor Mark Nelson (1)
- Biology: Student Scholarship & Creative Works (1)
- Channels: Where Disciplines Meet (1)
- Dissertations (1)
- Electronic Theses and Dissertations (1)
- Electronic Thesis and Dissertation Repository (1)
- Faculty Scholarship (1)
- GW Research Days 2016 - 2020 (1)
- Georgia State Undergraduate Research Conference (1)
- Graduate School of Biomedical Sciences Theses and Dissertations (1)
- Graduate Student Theses, Dissertations, & Professional Papers (1)
- Graduate Theses and Dissertations (1)
- Graduate Theses, Dissertations, and Problem Reports (1)
- Honors Scholar Theses (1)
- Independent Study Project (ISP) Collection (1)
- Journal of Bioresource Management (1)
- Kurt Piepenbrink (1)
- MSU Graduate Theses (1)
- Publication Type
- File Type
Articles 61 - 64 of 64
Full-Text Articles in Immunoprophylaxis and Therapy
Resilience To Resistance Of Hiv-1 Protease Inhibitors: Profile Of Darunavir, Eric Lefebvre, Celia A. Schiffer
Resilience To Resistance Of Hiv-1 Protease Inhibitors: Profile Of Darunavir, Eric Lefebvre, Celia A. Schiffer
Celia A. Schiffer
The current effectiveness of HAART in the management of HIV infection is compromised by the emergence of extensively cross-resistant strains of HIV-1, requiring a significant need for new therapeutic agents. Due to its crucial role in viral maturation and therefore HIV-1 replication and infectivity, the HIV-1 protease continues to be a major development target for antiretroviral therapy. However, new protease inhibitors must have higher thresholds to the development of resistance and cross-resistance. Research has demonstrated that the binding characteristics between a protease inhibitor and the active site of the HIV-1 protease are key factors in the development of resistance. More …
Efficacy And Mechanism Of Â-Defensin2 Fused Antigen Protein Vaccines, Hyun J. Park
Efficacy And Mechanism Of Â-Defensin2 Fused Antigen Protein Vaccines, Hyun J. Park
Dissertations & Theses (Open Access)
Vaccines which use the strategy of fusing adjuvant murine â-defensin2 (mBD2) to an antigen in order to elicit stronger anti-antigen immune responses are referred to as murine â-defensin2 (mBD2) vaccines. Previous studies have validated the potential of mBD2 vaccines, thus in this study we focus on increasing vaccine efficacy as well as mechanism elucidation. Initially, we demonstrate superior IFN-ã release levels by antigen specific effector T cells when antigen is crosspresented by dendritic cells (DC) which absorbed mBD2 vaccine (mBD2 fused antigen protein) over antigen alone. We move unto an in vivo model and note significant increases in the expansion …
Identification Of Novel Antimalarials From Marine Natural Products For Lead Discovery, Stephenie M. Alvarado
Identification Of Novel Antimalarials From Marine Natural Products For Lead Discovery, Stephenie M. Alvarado
Electronic Theses and Dissertations
An estimated 500 million cases of malaria occur each year. The increasing prevalence of drug resistant strains of Plasmodium in most malaria endemic areas has significantly reduced the efficacy of current antimalarial drugs for prophylaxis and treatment of this disease. Therefore, discovery of new, inexpensive, and effective drugs are urgently needed to combat this disease. Marine biodiversity is an enormous source of novel chemical entities and has been barely investigated for antimalarial drug discovery. In an effort to discover novel therapeutics for malaria, we studied the antimalarial activities of a unique marine-derived peak fraction library provided by Harbor Branch Oceanographic …
Premature Induction Of An Immunosuppressive Regulatory T Cell Response During Acute Simian Immunodeficiency Virus Infection, Jacob D. Estes, Qingsheng Li, Matthew R. Reynolds, Stephen W. Wietgrefe, Lijie Duan, Timothy Schacker, Louis J. Picker, David I. Watkins, Jeffrey D. Lifson, Cavan Reilly, John V. Carlis, Ashley T. Haase
Premature Induction Of An Immunosuppressive Regulatory T Cell Response During Acute Simian Immunodeficiency Virus Infection, Jacob D. Estes, Qingsheng Li, Matthew R. Reynolds, Stephen W. Wietgrefe, Lijie Duan, Timothy Schacker, Louis J. Picker, David I. Watkins, Jeffrey D. Lifson, Cavan Reilly, John V. Carlis, Ashley T. Haase
Qingsheng Li Publications
Here we report the results of an investigation into the possibility that one mechanism responsible for the establishment of persistent human immunodeficiency virus infection is an early regulatory T (Treg) cell response that blunts virus- specific responses. Using the simian immunodeficiency virus (SIV)–infected rhesus macaque model, we show that, indeed, viral replication and immune activation in lymphatic tissue drive a premature immunosuppressive response, with dramatic increases in the frequencies of CD4+CD25+FOXP3+ Treg cells, transforming growth factor–β1+ cells, interleukin–10+ cells, and indoleamine 2,3-dioxygenase+CD3+ cells.When we compared SIV infection with rhesus cytomegalovirus (RhCMV) …